Cas:562043-82-7 Ascorbic acid 2-glucoside manufacturer & supplier

We serve Chemical Name:Ascorbic acid 2-glucoside CAS:562043-82-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Ascorbic acid 2-glucoside

Chemical Name:Ascorbic acid 2-glucoside
CAS.NO:562043-82-7
Synonyms:Ascorbic acid 2-glucoside
Molecular Formula:C12H18O11
Molecular Weight:338.26472
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:
Exact Mass:
LogP:

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Ascorbic acid 2-glucoside chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Ascorbic acid 2-glucoside physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Ascorbic acid 2-glucoside Use and application,Ascorbic acid 2-glucoside technical grade,usp/ep/jp grade.


Related News: The mode of cooperation between domestic API companies and large international companies can lower the export threshold. Ascorbic acid 2-glucoside manufacturer Biogen last month revived its plans to seek U.S. approval for its aducanumab treatment after announcing in March that it would terminate two large clinical trials for the drug. But some analysts believed FDA approval is highly unlikely. Ascorbic acid 2-glucoside supplier Biogen last month revived its plans to seek U.S. approval for its aducanumab treatment after announcing in March that it would terminate two large clinical trials for the drug. But some analysts believed FDA approval is highly unlikely. Ascorbic acid 2-glucoside vendor Standard respiratory support therapies are used to treat the symptoms and wait for the virus to be cleared by itself. Ascorbic acid 2-glucoside factory Fate Therapeutics�� iPSC product platform is supported by an intellectual property portfolio of over 250 issued patents and 150 pending patent applications.